CEO Healthcare Symposium
Anthony Spero has more than 20 years of experience in healthcare operations and business development within the acute and post-acute health care industry. As an operator in the post-acute space Mr. Spero has managed Skilled Nursing and Long Term Care Facilities, Independent and Assisted Living Facilities, CCRC’s and Long Term Acute Care Hospitals. Currently as President of Ascend Health, he leads the company’s multi-state operation focused on providing best-in-class hospice, home health and concierge home care services. Previously, Mr. Spero worked as the National Vice President of Business Development at Golden Living. Mr. Spero received his Master’s Degree in Healthcare Administration and his MBA in Finance from Suffolk University. He is a licensed nursing home administrator and is most proud of his employment as a certified nursing assistant completed very early on in his healthcare career. In 2015 Mr. Spero was a speaker at the AHCA Quality Symposium and the Home Care Leadership Summit and presented on the topic of “People Centered Care”.
Ms. Cindy Bo has worked in healthcare strategy for over 20 years, ranging across the provider, payor and life sciences sectors.
She is named by the Becker's Hospital Review in 2016 and 2015 as one of the top 130 women hospital and health system
leaders to know in the United States.
Ms. Bo has expertise in strategic planning, business development, mergers and acquisitions and finance transformation. She has
worked collaboratively with executive leaders across the healthcare industry to improve the viability of healthcare delivery and
management of population health. Currently, she is the Chief Strategy & Business Development Officer for Nemours Children’s
Health System, Alfred I. duPont Hospital for Children. At Nemours, she manages the strategies and business development
processes in support of new growth and integration opportunities for both the hospital and practice in the Delaware Valley. She
also develops new strategic partnerships with clinical partners and other healthcare vendors. Ms. Bo drives the business
planning process for clinical services and programs. She is also co-leading the Nemours Value-Based Services Organization, as
Nemours transitions to value.
Prior to joining Nemours, she was a Senior Manager and an Ellen Gabriel Fellow at Deloitte, in the Healthcare M&A Practice. At
Deloitte, she led the strategic transformation for large regional health systems; led the M&A deals for national and regional
health plans, health systems and pharmacy benefit managers; and led revenue cycle management for major provider systems
around the US. Ms. Bo was also a Director at Novartis, leading the Business Planning & Analysis, Center of Excellence where she
managed the strategic planning for Novartis’ North American Primary Care portfolio.
Ms. Bo is a Malcolm Baldrige Executive Fellow and a graduate of the Disparities Leadership Program, working with
Massachusetts General Hospital. She is also an Aspen Institute Scholar. She is also an appointed Member by Governor John
Carney on the Delaware Economic and Financial Advisory Council. Ms. Bo is currently serving on several distinguished Boards.
She is a Board Member for the Clinic for Special Children in Strasburg, PA, the American Lung Association for the Mid-Atlantic
and the Delaware Center for Health Innovation. She is an Executive Team Member of the United Way of Delaware Young
United Professionals. She currently volunteers for the Nemours Children’s Health System, Alfred I. duPont Hospital for Children
and the Ronald McDonald House of Delaware. In the past, she has volunteered for City Year in Philadelphia, PA; Dekalb
Community Service Board in Atlanta, GA; and The William J. Clinton Foundation in New York, NY.
On the personal side, she is an avid runner, writes children’s stories, creates greeting cards and enjoys spending time with her
husband, David, and sons, Matthew (age 18) and Lucas (age 4).
Ms. Bo has earned her MBA, with high distinction and honors, from Columbia Business School and her BS, summa cum laude,
from Binghamton University School of Management.
Daniel Blum has served as President and CEO of Phelps Memorial Hospital Center since December 2014. Prior to joining Phelps as Senior Vice President in 2009, Mr. Blum served as Senior Vice President of White Plains Hospital Center, Vice President of Operations of Stellaris Health Network, and Operations Manager at St. Vincents Hospital and Medical Center in New York City. Mr. Blum began his healthcare career as a paramedic and paramedic instructor in New York City and worked at several New York City hospitals in a clinical and administrative capacity. Mr. Blum holds a bachelors degree in philosophy and a masters degree in healthcare administration, both from New York University. He is a member of the American College of Healthcare Executives and Medical Group Management Association. Mr. Blum is also Chairman of the NYS Department of Health Emergency Medical Advisory Council. Mr. Blum serves as collaborating administrative executive on Phelps Graduate Medical Education Committee and Chairman of the hospitals affiliated child care center.
Dan Murrey is an Orthopedic Spine Surgeon and CEO of Transformant Healthcare solutions (THS).
Dan previously served as CEO of OrthoCarolina, one of the largest orthopedic practices in the country with 160 physicians and 1400 employees throughout the Piedmont of western North Carolina. As CEO, he led efforts in quality improvement, data management, corporate compliance, customer service and contracting innovation. He is also an active researcher and educator, and is a patent-holder and developer of multiple spine care devices.
Transformant Healthcare Solutions (THS) is a management services company that partners with independent physician practices in order to transform the delivery and financing of healthcare, bringing a platform to lower cost of care, improve patient outcomes and enhance the patient experience.
In addition to his role as a physician leader, Dan serves on a number of nonprofit and healthcare boards and speaks about healthcare transformation throughout the country.
David Berry joined Flagship in 2005 where he focuses on innovating, entrepreneuring, and investing in new ventures in life sciences and sustainability. He is a founder of Flagship portfolio companies Joule Unlimited, Eleven Biotherapeutics (NASDAQ: EBIO), Seres Therapeutics (NASDAQ: MCRB), Pronutria Biosciences, LS9 (acquired by Renewable Energy Group) and Indigo. Prior to Flagship, David received an MD from Harvard Medical School and a PhD from the MIT Biological Engineering Division, working in the laboratories of Professors Ram Sasisekharan and Bob Langer, completing the dual degree in just over 5 years.
David currently serves on the Leadership Council of the United Nations Sustainable Development Solutions Network. He is currently on the Boards of the Hackley School and the Juventas New Music Ensemble, and has served on the MIT Corporation, its Board of Trustees as well as the Boston Philharmonic Orchestra. David was elected a 2014 Young Global Leader by the World Economic Forum.
Previously, David was named the Innovator of the Year by Technology Review, and received the prestigious Lemelson-MIT Student Prize for invention and innovation. He was also selected by the US State Department as 1 of 12 Innovators Helping to Reshape Reality.
Since 2012, David Boucher has served as President and Chief Operating Officer of UCI Medical Affiliates, Inc. the management company for the 55 Doctors Care urgent care centers, 24 Progressive Physical Therapy, and Doctors Wellness brands. UCI is a wholly-owned subsidiary of BlueCross BlueShield of South Carolina. From 2006, David Boucher has also served as President and Chief Operating Officer of Companion Global Healthcare, Inc., also a wholly-owned subsidiary of BlueCross. David has been able to examine firsthand the best practices in hospital care in 28 countries. Prior to rejoining BlueCross in 1999, David worked in Quorum Health Resources hospitals for fourteen (14) years, the last several as CEO in North and South Carolina facilities. David earned his Bachelor of Science in Community Health Administration at Slippery Rock University (PA) and his Master of Public Health degree in Administration at the University of South Carolina. David is a Fellow in the American College of Healthcare Executives and a 25+ year member of the Healthcare Financial Management Association. He has been active in numerous community organizations over the years - participating at the Board of Director level for the Columbia Free Medical Clinic, the Rotary Club of Spring Valley, the South Carolina Philharmonic, and the Columbia World Affairs Council. He recently concluded his tenure as the president of the Capital Rotary Club in Columbia. David also coached youth soccer for 21 years. Over the past few years, David has been quoted in over 250 national publications including US News & World Reports, Business Week, Fast Company, The New York Times, Wall Street Journal, The New Yorker, The Economist (x4), Good Housekeeping plus NBC Nightly News and Fox Business News. David has made presentations on disruptive innovation in healthcare to a number of audiences including Harvard Medical School, Harvard Business School, Yale University, and AARP.
Douglas Fambrough is a co-founder of Dicerna Pharmaceuticals and joined the company as CEO in May 2010. Prior to joining Dicerna, Dr. Fambrough spent over a decade as a biotechnology venture capitalist with Oxford Bioscience Partners, one of Dicerna’s investors. At Oxford, he specialized in financing innovative life science technology companies such as the first generation RNA interference company, Sirna Therapeutics (acquired by Merck). Among his other investments are high-throughput DNA sequencing pioneer Solexa (acquired by Illumina); Xencor, which engineers antibody Fc domains to enhance drug properties; Rib-X Pharmaceuticals, a developer of antibiotics against multi-drug resistant pathogens; and Solstice Neurosciences (acquired by US WorldMeds). Prior to Oxford, Dr. Fambrough was a genomic scientist at the Whitehead/MIT Center for Genome Research (now known as the Broad Institute). Dr. Fambrough graduated from Cornell University and holds a Ph.D. in genetics from the University of California, Berkeley.
Jeffrey Wolf is the founder and CEO of Heat Biologics. He was formerly the founder and managing director at Seed-One Ventures, a firm focused on the systematic formation and management of new biomedical companies based upon novel research breakthroughs.
Throughout his career Mr. Wolf has created life science startup companies and actively supported the growth of these companies. Mr. Wolf’s start-ups include Avigen (co-founder and director), a NASDAQ-listed gene therapy company; TyRx Pharma (co-founder and Chairman) which was focused on the development of novel bio-compatible polymers and recently sold to Medtronic; EluSys Therapeutics (founder and CEO), focused on the development of novel antibodies against infectious diseases and GenerationOne (founder and CEO), focused on mobile-based healthcare solutions.
Mr. Wolf received his M.B.A. from Stanford Business School, his J.D. from New York University School of Law and his B.A. from the University of Chicago, where he graduated with honors in Economics.
James E. Shmerling was named President and Chief Executive Officer at Connecticut Childrens Medical Center on October 1, 2015. For over three decades, Dr. Shmerling has served in management roles in childrens hospitals and is nationally recognized as a leader in issues concerning childrens health and wellness. Prior to joining Connecticut Childrens, Dr. Shmerling spent the last eight years as the Chief Executive Officer of Childrens Hospital Colorado, one of the top ranked childrens hospitals in the nation. Before that, he was the Executive Director and Chief Executive Officer of the Monroe Carell Jr. Childrens Hospital at Vanderbilt from 2002 to 2007. He was the Senior Vice President of Methodist Healthcare and President of Le Bonheur Childrens Medical Center from 1995 to 2002, and was Le Bonheurs Chief Operating Officer from 1991 to 1995. He served as the Associate Director of Hospitals at Indiana University Hospitals and Administrator of the James Whitcomb Riley Hospital for Children from 1987 to 1991. Dr. Shmerlings career in childrens hospitals began in the Childrens Hospital of Alabama where he progressed in administrative responsibilities from 1979 to1987, the last of which was as its Associate Administrator. He earned his Bachelor of Science Degree in Health Education from the University of Tennessee in 1976. In 1980, he was awarded a Master of Science Degree in Hospital and Health Administration from the University of Alabama at Birmingham. He earned a Master of Business Administration from Samford University in 1984 and his Doctorate of Health Administration from the Medical University of South Carolina in 1999. Dr. Shmerling is a Fellow in the American College of Health Care Executives (ACHE). He is an adjunct faculty member in the Hospital Administration programs, University of Alabama at Birmingham. Additionally, Dr. Shmerling is active in several national healthcare organizations. Currently he serves as: Board member of the Childrens Hospital Group, Dublin, Ireland Immediate Past Chair of the Board of Childrens Miracle Network Hospitals, Salt Lake City, Utah Immediate Past Chair of the Board of Childrens Hospital Association, Alexandria, VA Chair of the Child Health Patient Safety Organization, Inc., Overland Park, KS, a component entity of the Childrens Hospital Association Chair Elect on the Governing Council of the American Hospital Associations Section for Maternal and Child Health, Washington, D.C. Past Board Chair of the Colorado Regional Health Information Organization (CORHIO), Denver, Colorado Dr. Shmerling is a native of Nashville, Tennessee.
José Baselga is the Physician-in-Chief at Memorial Sloan Kettering Cancer Center (MSK) and
Professor of Medicine at Weill Cornell Medical College. His long standing research interests are
in the development of targeted agents for the treatment of breast cancer and in studying
strategies to overcome mechanisms of resistance, with over 457 peer-reviewed publications to
date. He conducted pivotal laboratory and clinical studies that led to the approval of
trastuzumab, pertuzumab and everolimus, among other therapies. His current work is in
targeting PI3K and deciphering mechanisms of resistance to anti-estrogen therapies. Prior to
MSK, Dr. Baselga was the Chief of the Division of Hematology / Oncology, Associate Director of
the Massachusetts General Hospital Cancer Center and Professor of Medicine at Harvard
Medical School. He was also the Chairman of Medical Oncology and Founding Director of the
Vall d’Hebron Institute of Oncology in Barcelona, Spain. Dr. Baselga is a past President of the
American Association of Cancer Research (AACR), a past President of the European Society
for Medical Oncology, and a past member of the Board of Directors for the American Society of
Clinical Oncology. He is an elected member of the National Academy of Medicine, the
American Society of Clinical Investigation, the Association of American Physicians, and a Fellow
of the AACR Academy. He is a past member of the Editorial Boards of Cancer Cell, Journal of
Clinical Oncology, and Clinical Cancer Research and is the founding editor-in-chief for the
AACR flagship journal Cancer Discovery.
Karen Teitelbaum is the President/Chief Executive Officer at Sinai Health System, an urban, teaching healthcare system comprised of four hospitals, an epidemiological research institute focusing on healthcare disparities, a community institute with over 25 distinct programs, over 800 medical staff members, and 4,000 employees. Focused on the delivery of high quality services in an efficient and cost effective manner, Sinai Health System has achieved national recognition in quality while reducing costs by millions of dollars due to greater efficiency and management of population health. Karen serves on the boards of the Illinois Health and Hospital Association (Nominating and Governing Committee), Women in Health-Life Sciences, the David Lynch Foundation Advisory Council, and has served on the boards of the Metropolitan Chicago Healthcare Council, Family Health Network, the Theraplay Institute, Academy of Managed Care Pharmacy Foundation, and the Young Womens Leadership Charter School. She is a member of the American Hospital Association Task Force on Ensuring Access for Vulnerable Communities, and has been a member of the American Hospital Association Council on Maternal Fetal Health, and chaired the Building Committee for a significant Federally Qualified Healthcare Center. She is a member of the Economic Club of Chicago, The Chicago Network, and the Commercial Club of Chicago. She has been named one of 130 Nonprofit Hospital & Health System CEOs to Know by Becker´s Hospital Review, as well as being named one of the Leaders of Chicago Healthcare by the same publication. Karen has taught both graduate and undergraduate courses in managed care and marketing and strategy for nonprofit organizations, and is a frequently requested national speaker on healthcare delivery topics such as population health management in an urban environment. Karen holds a Masters of Management degree from Northwestern University, Kellogg School of Management.
Kevin B. Churchwell, MD, is the Executive Vice President of Health Affairs and Chief Operating Officer at Boston Childrens Hospital. He provides leadership, direction, integration and oversight for the medical delivery system, while partnering with the Chief Executive Officer on a full range of research, clinical, academic, operational and strategic issues. Prior to joining Boston Childrens Dr. Churchwell was Chief Executive Officer for Nemours/Alfred I. duPont Hospital for Children in Wilmington, DE. As the lead administrator in the Delaware Valley, Dr. Churchwell was actively driving efforts to increase the quality and affordability of care for all children. Under his leadership, the Leapfrog Group recognized Nemours duPont as one of 12 safest childrens hospitals. Dr. Churchwell also served as the CEO and Executive Director for the Monroe Carell Jr. Children's Hospital, part of the Vanderbilt University Medical Center in Nashville, TN. He previously served in several other capacities, including Chief-of-Staff, Medical Director for the Children's Health and Injury Prevention Program, Medical Director for the Pediatric Critical Care Services, and Transport Director. A graduate of Massachusetts Institute of Technology and Vanderbilt Medical School in Nashville, Dr. Churchwell completed his pediatric residency and a clinical fellowship in Anesthesia and Pediatric Critical Care at Boston Children's Hospital. Since 1993, Dr. Churchwell has been a clinician and faculty member at Vanderbilt University Medical Center. He is a diplomat for the National Board of Medical Examiners and is board certified with the American Board of Pediatrics. Dr. Churchwell was recently appointed the Robert and Dana Smith Associate Professor of Anesthesia at the Harvard Medical School.
An American success story! Breaking the glass ceiling 32 years ago - after 10 years in clinical practice and 6 years as a Vice President with large chain organizations - Louise, a Registered Nurse with a Masters from the Bloomberg Johns Hopkins School of Public Health founded ACCESS Nursing Services from her apartment in Manhattan, (and no money in her pocket),. Today, ACCESS Nursing enjoys the reputation as a leading regional provider of Clinical Services & Nursing Personnel. “ACCESS” cares for organizations and individuals, from the Bedside to the Boardroom, of large healthcare systems located in NY, NJ and Maryland. ACCESS Nursing is the 3 rd largest female-owned business in New York, and is of the top 3% of successful companies in North America.
Louise considers her “Special Sauce” to be her ability to listen to the client’s problems and develop a clinically strategic Nursing Management & Workforce Solution that provides Better Care at a Lower Cost while keeping Patients and Providers HAPPY!. A mother of 2 living in Westchester, NY - Louise continues to own the company 100% herself and ACCESS’ 10 branches employ over 2,000 caregivers and manages $35 million in Revenues.
No matter what the challenge, Louise is a tough competitor that loves to WIN! Her trophy cabinet contains awards for tennis, golf, skiing, marathon running, boating, hiking, biking and swimming. Weadock believes the required “COMMITMENT to Winning” in business is No Different than in sport! Louise is on the Board of Johns Hopkins School of Nursing and she is considered a thought leader in the area of Pediatric Autism Spectrum Disorders.
Martha Schram is the President of Aegis Therapies, a position she has held since 2004. Ms. Schram is responsible for the overall leadership and direction of Aegis, including the management of the contract rehabilitation and wellness services Aegis provides to healthcare organizations and the oversight of Aegis growing home health, outpatient and wellness business. Aegis clients include skilled nursing facilities, assisted living facilities, independent living facilities, continuing care retirement communities, home care organizations and individuals utilizing Aegis Medically Oriented Gyms and outpatient rehabilitation services. Prior to becoming President of Aegis, Ms. Schram was a Division Vice President and Group Vice President for Aegis. Her varied and successful career prior to Aegis includes serving as an Area Vice President for NovaCare in Wisconsin; an Executive Director of Rehabilitation Services for Divine Savior Healthcare in Portage, Wisconsin; and Clinical Coordinator for the Veterans Affairs Medical Center in Madison, Wisconsin. Earlier in her career, Ms. Schram held a variety of senior management and leadership positions with increasing responsibility in geriatric healthcare businesses. Ms. Schram earned a Bachelor of Science Degree in Physical Therapy from the University of Colorado at Boulder. She serves on the Board of Directors of the National Association for the Support of Long-Term Care (NASL), and is Chairman of the NASL Medical Services Committee. She is also a member of The University of Colorado Physical Therapy Scholarship Endowment Board and the International Council on Active Aging Advisory Board.
Matt Murphy is currently President and CEO at Griswold International LLC, one of the nation's oldest non-medical home care franchise brands. Griswold operates over 200 locations in 32 states, and has both owned and franchised locations. Prior to joining Griswold, Matt was CEO of Financial Health Services, LLC, a third party billing and revenue cycle management business that services the senior care market. Between both businesses, Matt has dedicated the last 5 years to supporting passionate business owners who are committed to helping aging and disabled adults live independently. Prior to joining FHS, Matt spent 7 years with RecruitMilitary, a company specializing in helping veterans and their spouses connect with employers, and worked on everything from business development, to leading the sales force, to the role of Chief Operating Officer. During that time the company more than doubled in employees, while revenues and net income grew by double digits every year. Before that, he served as Vice President and Chief Operating Officer at Acquisition Management Services, Inc., a company that helped companies grow by acquisition. Prior to joining AMS, Matt was an in-house attorney for the University of Pennsylvania Health System, where he supported the systems network development and corporate growth activities. During the period between his undergraduate and legal studies, Matt was a Surface Warfare Officer in the United States Navy. While in the Navy, Matt served on the USS Hepburn (FF-1055) as the Gunnery Officer, Command Information Center Officer, and ultimately as Navigator. Matt holds a Bachelor of Science degree in Applied Science and Technology from Rochester Institute of Technology, and a Juris Doctorate from the State University of New York at Buffalo.
Matthew L. Plaud is an accomplished executive with over twenty years of experience in a highly regulated environment. Currently he is the CEO of SOTIO, LLC, the North American arm of the SOTIO Group. In his three years with SOTIO, he has risen through the ranks from starting as the Director of Apheresis Network Management, to taking on all aspects of Logistics, to ultimately being promoted to the CEO of the US operation. In his time in this role he has improved staff moral while enacting major savings programs.
Before joining SOTIO, Matthew held a series of progressively responsible roles within the American Red Cross. Starting as a laboratory technician, he spent over 17 years working in different areas of the organization until ultimately completing as the interim CEO of the Massachusetts Region.
Although his career was initiated in the laboratory, Matthew has spent his time expanding his knowledge of business and management. He is a graduate of UMass with a degree in Human Resource Management (Summa Cum Laude) and then went on to Eastern Nazarene College to earn a Master’s of Science in Management. He is passionate about his work and enjoys mentoring up-and-coming staff.
Pauline Corso is Operational Vice President and Chief Operating Officer, Delaware Valley Physician Network for Nemours Children’s Health System, a role she’s held since 2015. Her responsibilities include managing a group of 380 employed physicians across 30 Delaware Valley sites including the Nemours/Alfred I. duPont Hospital for Children in Wilmington, DE. Pauline oversees new and existing partnerships and manages nearly a dozen existing external health organization pediatric partnerships throughout Delaware, Maryland, New Jersey and Pennsylvania. Pauline has been successful at growing innovative programs at Partner hospitals to keep care local. Prior to being named Chief Operating Officer, Pauline served as Physician Practice Administrator for Nemours Delaware Valley. She continues to oversee and manage all aspects of Practice Operations throughout the network.
Pauline is an active member of the American Association of Medical Colleges, Association of Academic Administrators in Pediatrics as well as the American College of Healthcare Executives. Pauline is also an active contributor to professional organizations and conferences around the nation. She has also served on the American Lung Association Mid-Atlantic Board.
Born and raised in Philadelphia, Pauline currently resides in West Deptford, NJ. She holds a Bachelor of Science Degree in Business Administration from Peirce College in Philadelphia where she received the President’s List Achievement Award in Business Administration.
Preston Brice joined MBF Healthcare Partners as a managing director in 2016 and has spent the last 10+ years focused on the healthcare services sector. Most recently he was with Apple Tree Partners (ATP), a $1.5 Bn healthcare focused venture capital/ growth equity fund. During his time at ATP, Preston served as the interim CEO and a Director of Cure Forward (precision medicine technology platform) in addition to being a Board Observer for Clean Slate Addiction Treatment Centers, TripleCare (telemedicine for SNFs) and QualDerm Partners (dermatology practices). Preston has held roles in private equity and investment banking (both M&A as well as leveraged finance) including time at The Beekman Group, a middle market private equity fund, and CIT Group, a middle market investment bank.
Preston earned his M.B.A. from Columbia Business School, where he achieved Dean’s Honors and Distinction and holds a B.S. in Business Administration from Boston University’s School of Management where he graduated magna cum laude.
MBF Healthcare Partners is a healthcare focused private equity fund specializing in strategic growth equity investments and majority recapitalizations of middle market companies. Founded by successful operating executives, we not only understand the day to day challenges of growing a business but also have deep insights into what it takes to succeed in today’s shift to value based care. We are actively looking for executives with whom to partner as we deploy our second fund. Our target initial equity check is $20MM to $50MM per deal.
As chief executive officer of Magellan Healthcare, Sam Srivastava focuses on improving health and affordability through advanced analytics and clinical solutions. He leads the strategy development, operations, product development and management, and profitability and growth of Magellan Healthcare, while positioning Magellan as a leader in the behavioral health, Medicaid and specialty healthcare markets. Srivastava also provides leadership over enterprise strategy, communication and government affairs. Prior to joining Magellan, Srivastava worked at Cigna where he was president of the national and senior business segments. He had executive management responsibility for the strategic planning, business operations, growth and financial performance for these segments, which serve approximately 18 million individuals. He was instrumental in the acquisition of HealthSpring and the pharmacy benefit management partnership with CatamaranRx. Srivastava has held executive leadership positions in the commercial, senior, low-income and disabled population segments at UnitedHealth Group and HealthNet, and served as a management consultant in the United States and internationally, primarily focusing on the areas of developing and improving integrated health care delivery systems for providers, insurers and governments. Srivastava graduated from Kent State University with a bachelors degree in medical science and humanities, and completed graduate work at Yale University in healthcare management. He also sits on a number of advisory boards, including Oliver Wyman, Yale School of Public Health and Yale Healthcare Conference. He is married to Dr. Lisbet Lundsberg, a member of the faculty at the Yale School of Medicine, and resides in Wilton, Conn. with their four daughters.
Steven H. Stein, MD is the Chief Medical Officer at Incyte Corporation. In this role, Dr. Steins primary responsibility is leading all the medical and scientific activities involving clinical development, clinical operations, pharmacovigilance, clinical pharmacology, scientific communications and medical affairs at Incyte Dr. Stein previously worked at Novartis Oncology as the Senior Vice President and Head of U.S. Clinical Development and Medical Affairs and prior to that at GlaxoSmithKline as Vice President, Global Oncology, Clinical Development and also as Head of Medicines Development for Hematology and Supportive Care. Dr. Stein earned his MBBCH from the University of Witwatersrand in Johannesburg, South Africa. He has authored more than 100 scientific papers and presentations and is an Adjunct Assistant Professor in the School of Medicine, University of Pennsylvania. Dr. Stein is also an active member of several professional and scientific societies and academic committees.
Dr. Neuwirth began his career as an academic general internist with a particular focus on healthcare communication and relationship- centered care. His articles on humanism in health care have been published in medical journals as well as in the New York Times and Newsweek; and his efforts to improve healthcare delivery have also been featured in Forbes, Fast Company, WebMD, the Yale School of Management Journal, The Boston Globe and The Charlotte Observer. Zeev currently serves as Senior Medical Director of Primary Care within the Carolinas Healthcare System Medical Group a 1900 provider multi-specialty network. In addition, he is an executive leader for core strategic initiatives focused on Population Health Management, Payment Alignment, Primary & Specialty Care Redesign, Corporate Health, and Retail Medicine. Dr. Neuwirth has been deeply engaged in community health and mHealth innovations while at Carolinas. In 2012, he was selected as one of 70 participants from a pool of over 1000 applicants, into the CMMS Innovation Fellows program. In 2014, he received an Innovation in Healthcare award from the Charlotte Business Journal. He currently functions as an advisor to a number of healthcare start-ups. Prior to his current role at Carolinas, Zeev served as Chief of Clinical Effectiveness & Innovation at Harvard Vanguard Medical Associates, a 600 physician multi-specialty practice located in Eastern Massachusetts. In 2011, during his tenure at Harvard Vanguard, Zeev received the first Mayoral Award for Innovation in Healthcare from then Boston Mayor, Thomas Menino. Zeev attended Tufts University undergrad, The University of Pennsylvania School of Medicine, and completed his internship and residency in Internal Medicine at the Mount Sinai Hospital in Manhattan. In addition to his medical training, Dr. Neuwirth is a certified family and group therapist, having trained at the renowned Ackerman Institute for the Family. He holds a Masters degree in Health Care Management from the Harvard School of Public Health where he has also taught courses on health care strategy to physician executives in a Masters level program.
To Be Announced
This event starts on February 12th at 5:00 PM.
On February 12th & 13th, 2018, YJP will be hosting its CEO Healthcare Symposium. Featuring speakers from the hospital, insurance, biotech, pharma, medical device, medtech, senior living, and home care sectors, this event will bring together top executives from across the healthcare spectrum to discuss the current and future market trends that we are seeing in the industry.
The breakout sessions, featuring our signature YJP format for maximum interaction and value, will focus on topics such as:
-The Future of Post-Acute Care
-Investing in Healthcare
-Positioning Your Organization for the Future
-Advances in Immuno-Oncology
-Transitioning to Value-Based Care
...and many more!
Join us for two days of stimulating conversation, gourmet food and drink, and high-level networking with the top names in healthcare.